Abstract A treatment for senile dementia of the Alzheimer's type comprising administering to the patient a tertiary amine of the formula <IMAGE> Formula 1 wherein R1 is alkyl, alkoxy, alkylthio or dialkylamino hydroxyl, hydrogen, chlorine or fluorine; R2 is hydrogen, or when R1 is hydrogen, alkyl, alkoxy, alkylthio, alkylthioamino, hydroxyl, chlorine or fluorine; R3 is 1 to 2 carbon alkyl; R4 is 1 to 3 carbon alkyl; R5 is an optionally branched 3 to 12 carbon alkylene; X is oxygen or ethylene dioxy; and R6 is optionally branched or cyclic carbon group having less than eight carbons. The preferred compound is secoverine. The administration of secoverine may be used in conjunction with the coadministration of a cholinergic enhancer, for example, in a combination with acetylcholinesterase inhibitors, muscarinic agonists or choline supplement therapy.
Inventors
👤 Adolph P. Roszkowski
Bibliographic Details
Application Number—
JurisdictionUS
Data Sourcegoogle_patents
Last Synchronized2026-10-29 05:07
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
187 words
A method for treating a patient having Alzheimer's disease comprising administering to the patient a pharmaceutically effective amount of a compound of the formula: ##STR3## in which R 1 represents an alkyl group, an alkoxy group, an alkylthio group or dialkylamino group having up to 2 carbon atoms per substituent, a hydroxyl group, a hydrogen atom, a chlorine atom or a fluorine atom; and R 2 is a hydrogen atom; or R 1 represents a hydrogen atom in addition to one of the remaining meanings of R 1 , while R 1 and R 2 may both represent alkoxy groups having up to 2 carbon atoms; R 3 is an alkyl group having up to 2 carbon atoms; R 4 is an alkyl group having up to 3 carbon atoms; R 5 is a branched or nonbranched alkylene group having 3 to 12 carbon atoms; R 6 is branched or nonbranched or cyclized alkyl group having up to 8 carbon atoms; and R 5 together with R 6 contains at least 6 carbon atoms; and salts formed with pharmaceutically acceptable acids; and a pharmaceutically acceptable carrier therefore.
Claim 2
Independent Claim
187 words
A method for treating a patient having Alzheimer's disease comprising administering to the patient a pharmaceutically effective amount of a compound of the formula: ##STR3## in which R 1 represents an alkyl group, an alkoxy group, an alkylthio group or dialkylamino group having up to 2 carbon atoms per substituent, a hydroxyl group, a hydrogen atom, a chlorine atom or a fluorine atom; and R 2 is a hydrogen atom; or R 1 represents a hydrogen atom in addition to one of the remaining meanings of R 1 , while R 1 and R 2 may both represent alkoxy groups having up to 2 carbon atoms; R 3 is an alkyl group having up to 2 carbon atoms; R 4 is an alkyl group having up to 3 carbon atoms; R 5 is a branched or nonbranched alkylene group having 3 to 12 carbon atoms; R 6 is branched or nonbranched or cyclized alkyl group having up to 8 carbon atoms; and R 5 together with R 6 contains at least 6 carbon atoms; and salts formed with pharmaceutically acceptable acids; and a pharmaceutically acceptable carrier therefore.
Claim 3
Dependent Claim
10 words
The method of claim 1 wherein said compound is secoverine.
Claim 4
Dependent Claim
18 words
The method of claim 1 wherein the amount of said compound is between 0.01 mg/kg and 10.0 mg/kg.